» Articles » PMID: 16210054

Respiratory Syncytial Virus and Other Respiratory Viruses During the First 3 Months of Life Promote a Local TH2-like Response

Overview
Date 2005 Oct 8
PMID 16210054
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Respiratory syncytial virus (RSV) infections during infancy are considered to be a risk factor for developing asthma and possibly allergic sensitization.

Objective: The aim of this study was to investigate the cytokines, chemokines, and eosinophil cationic protein in the nasopharyngeal secretions of infants < or = 7 months of age with RSV infections or other respiratory viral infections and healthy infants as controls. Groups were also analyzed according to age, < or = 3 months and >3 months, and the levels were compared within and between groups.

Results: Thirty-nine infants with RSV, 9 with influenza or parainfluenza virus infections and 50 controls with no history of infections, were enrolled in the study. The RSV-infected infants had significantly higher levels of IL-4; macrophage inflammatory protein 1beta, a chemoattractant for T cells; and eosinophil cationic protein in nasopharyngeal secretions compared with the control group. The levels of the TH2 cytokine IL-4 were significantly higher in RSV-infected infants < or = months of age compared with RSV-infected infants >3 months of age. In infants < or = 3 months of age, infections with influenza or parainfluenza virus caused TH2-like responses similar to those produced by RSV.

Conclusion: Infections with RSV as well as with influenza and parainfluenza virus during early infancy preferentially promote a TH2-like response in the nose with local production of IL-4, IL-5, and macrophage inflammatory protein 1beta and infiltration and activation of eosinophils.

Citing Articles

Characterizing Non-T2 Asthma: Key Pathways and Molecular Implications Indicative of Attenuated Th2 Response.

Lee J, Yang Y, Lin Y, Wang L, Yu H, Hu Y Inflammation. 2024; .

PMID: 39466498 DOI: 10.1007/s10753-024-02159-3.


A clinical protocol for a German birth cohort study of the Maturation of Immunity Against respiratory viral Infections (MIAI).

Hartmann C, Khan R, Schoning J, Richter M, Willers M, Pirr S Front Immunol. 2024; 15:1443665.

PMID: 39355253 PMC: 11442434. DOI: 10.3389/fimmu.2024.1443665.


Modeling Human Respiratory Syncytial Virus (RSV) Infection: Recent Contributions and Future Directions Using the Calf Model of Bovine RSV Disease.

Diaz F, McGill J J Immunol. 2023; 211(8):1180-1186.

PMID: 37782855 PMC: 10558079. DOI: 10.4049/jimmunol.2300260.


Molecular Profiling of Inflammatory Mediators in Human Respiratory Syncytial Virus and Human Bocavirus Infection.

Alkubaisi N, Aziz I, Alsaleh A, Alhetheel A, Almajhdi F Genes (Basel). 2023; 14(5).

PMID: 37239461 PMC: 10218554. DOI: 10.3390/genes14051101.


Immune phenotype is differentially affected by changing the type of bovine respiratory disease vaccine administered at revaccination in beef heifers.

Reddout C, Hernandez L, Chase C, Beck P, White F, Salak-Johnson J Front Vet Sci. 2023; 10:1161902.

PMID: 37138923 PMC: 10149669. DOI: 10.3389/fvets.2023.1161902.